| | 
Part, Chapter, Paragraph
1 -, 1 | enlargement to 25 countries in 2004 and to 27 countries in 2007,
2 I, 2. 2 | than 700 billion euro in 2004 followed by the US, with
3 I, 2. 2 | 89%) into the EU during 2004 (Eurostat).~ ~The progressive
4 I, 2. 2 | growing in Europe. Since 2004 global international arrivals
5 I, 2. 2 | 56% in the period 1997 to 2004 and 26% in the opposite
6 I, 2. 4 | members of the EU before 2004 and of those who joined
7 I, 2. 4 | those who joined the EU in 2004.~ ~Figure 2.2. Gross Domestic
8 I, 2. 4 | Employment and Social Affairs, 2004. As retired people generally
9 I, 2. 5 | provided for by the law.~ ~In 2004, the European Commission,
10 I, 2. 6 | ISCED levels 5 or 6) in 2003/2004~ ~This gap is evident throughout
11 I, 2. 6 | men (EUROSTAT, 2008).~ ~In 2004, women made up around 59%
12 I, 2. 6 | women than men graduated in 2004 in all countries except
13 I, 2. 6 | In the EU25 as a whole in 2004, 57% of those successfully
14 I, 2. 6 | on average in the Eu in 2004, the opposite occurs in
15 I, 2. 8 | Negligible~ ~Source: WHO (2004)~ ~Many health outcomes
16 I, 2. 10. 2 | risks (The Royal Society, 2004; NIOSH, 2006; Schulte et
17 I, 2. 11 | Luxembourg~The Royal Society (2004): Nanoscience and nanotechnologies,
18 I, 3.Acr | Acronyms~ ~EUROPOP 2004 2004-based European Population
19 I, 3.Acr | Acronyms~ ~EUROPOP 2004 2004-based European Population
20 I, 3. 2 | 2). Based on the EUROPOP 2004 baseline population projections,
21 I, 3. 2 | 37%). According to GCIM (2004), the number of first-generation
22 I, 3. 2 | put at 33 million (GCIM, 2004; HWWA 2004).~ ~During the
23 I, 3. 2 | million (GCIM, 2004; HWWA 2004).~ ~During the past 20 years,
24 I, 3. 3 | increased life expectancy. In 2004, Italy was the country with
25 I, 3. 3 | observation period (2000-2004) is Germany. Whereas the
26 I, 3. 3 | the period from 2000 to 2004. The recent value amounts
27 I, 3. 3 | value amounts to 26.8 for 2004, which corresponds to the
28 I, 3. 4 | International Migration (GCIM) (2004): GLOBAL MIGRATION PERSPECTIVES
29 I, 3. 4 | PERSPECTIVES No. 16, October 2004. Available at: htt ~ ~Hamburg
30 I, 3. 4 | International Economics (HWWA) (2004): Migrants in Europe and
31 II, 4.Acr | Health Survey System~EUROPOP 2004~2004-based European Population
32 II, 4.Acr | Survey System~EUROPOP 2004~2004-based European Population
33 II, 4. 1 | Commission introduced in 2004, under the name of “Healthy
34 II, 4. 1 | men) (Robine and Michel, 2004).~ ~Table 4.1.3 shows 10-
35 II, 4. 1 | Since its introduction in 2004 Healthy Life Years (HLY)
36 II, 4. 3 | J.-M. and J.-P. Michel (2004): Looking forward for a
37 II, 5. 1. 1 | dementia (Haan and Wallace, 2004). Whilst a low level of
38 II, 5. 2. 2 | Muller-Nordhorn et al, 2004] were published by the World
39 II, 5. 2. 3 | Society of Cardiology (ESC) in 2004 (Allender et al, 2008).
40 II, 5. 2. 4 | circumference (Yusuf et al, 2004) may play a more significant
41 II, 5. 2. 4 | CVD incidence (Wellman J, 2004).~Due to differences in
42 II, 5. 2. 4 | INTERHEART (Yusuf et al, 2004) case-control study, conducted
43 II, 5. 2. 5 | guidelines (Grundy SM et al, 2004, Graham I et al, 2007)~Within
44 II, 5. 2. 5 | Council Conclusion from 2004 (Council of the European
45 II, 5. 2. 5 | Council Meeting – 1 and 2 June 2004) on promoting cardiovascular
46 II, 5. 2. 7 | Stamler J, Pirzada A et al (2004): Favorable Cardiovascular
47 II, 5. 2. 7 | P, Varigo J, Lisheng A (2004): Effect of potentially
48 II, 5. 3. 3 | geographical area from 1980 to 2004 as supplied by the WHO.~-
49 II, 5. 3. 7 | stopped (Tsubono et al, 2004).~Ideally, an organised
50 II, 5. 3. 7 | Planning stage~NETHERLANDS~Yes (2004)~AUSTRIA~Yes (regional)~
51 II, 5. 3. 9 | Tsubono Y, Hisamichi S (2004):. A halt to neuroblastoma
52 II, 5. 4. 1 | worldwide (King 1998; Wild 2004). In the past, this form
53 II, 5. 4. 1 | countries (King 1998; Wild 2004).~ ~Figure 5.4.1. The Growing
54 II, 5. 4. 1 | Epidemic~ ~(WHO Report, 6 May, 2004)~ ~A complex interaction
55 II, 5. 4. 2 | feasible (Greenfield et al 2004, see Table 5.4.2), only
56 II, 5. 4. 2 | been included (Fleming, 2004).~In this case participants
57 II, 5. 4. 6 | the EU Health Council in 2004, under the Irish Presidency,
58 II, 5. 4. 6 | the Otocec Declaration (2004), signed by more than 80
59 II, 5. 4. 8 | Nicolucci A and Mattke S (2004): Selecting Indicators for
60 II, 5. 4. 8 | 10 October 2008)~Wil H (2004): Global prevalence of diabetes:
61 II, 5. 5.Int(8) | European Commission (2004): The State of Mental Health
62 II, 5. 5.Int(15)| deVries MW, Wilson KCM (2004): Depression among older
63 II, 5. 5.Int(18)| Tsuboi K, Dennerstein L.(2004): Prevalence of eating disorders:
64 II, 5. 5.Int | between social partners in 2004.~ ~The Community’s Framework
65 II, 5. 5.Int(20)| European Commission (2004): Action for Mental Health.
66 II, 5. 5.Int(20)| Public health Programmes 1997-2004. htt m. A list of all completed
67 II, 5. 5. 1 | suicide. For example in 2004 the total costs from depression
68 II, 5. 5. 1 | females) (Schmidtke et al, 2004).~ ~
69 II, 5. 5. 1 | depression” was prepared in 2004 by the Commission. The expert
70 II, 5. 5. 1 | and Prevention Policies (2004- ) was especially targeted
71 II, 5. 5. 1 | for the European level (2004-6), provided final set of
72 II, 5. 5. 1 | Public Health Programmes 1997-2004). Luxembourg: European Communities
73 II, 5. 5. 1 | Communities and STAKES, 2004.~ ~European Commission (
74 II, 5. 5. 1 | depression. European Communities, 2004. Also available online at:
75 II, 5. 5. 1 | Bille-Brahe U, De Leo D et al. (2004). Suicidal behaviour in
76 II, 5. 5. 2 | UK and Estonia were from 2004. Population statistics were
77 II, 5. 5. 2 | dementia (Haan and Wallace, 2004). Whilst a low level of
78 II, 5. 5. 2 | Haan MN and Wallace R (2004): Can dementia be prevented?
79 II, 5. 5. 3 | per decade (Misra et al, 2004; Gupta, 1995). Anorexia
80 II, 5. 5. 3 | time in 2001/2002 (WHO, 2004). A lot of European Union (
81 II, 5. 5. 3 | increases with age (WHO, 2004).~Berkman et al (2007) reviewed
82 II, 5. 5. 3 | anorectic or bulimic (NEDA, 2004):~· Psychological factors:
83 II, 5. 5. 3 | Herzog, D.B, Klibanski, A. (2004): Effects of Anorexia Nervosa
84 II, 5. 5. 3 | Disorders Association) (2004): What Causes Eating Disorders?
85 II, 5. 5. 3 | World Health Organization (2004): Health Policy for Children
86 II, 5. 5. 3 | European Region (Kohn et al, 2004). Evidence indicates that
87 II, 5. 5. 3 | installed (Häfner et al, 2004). During that time, dire
88 II, 5. 5. 3 | was 12 months (Kohn et al, 2004).~The percentage difference
89 II, 5. 5. 3 | was 32.2% (Kohn et al, 2004) worldwide; selected data
90 II, 5. 5. 3 | strategy (Demyttenaere, 2004; Middelboe, 2001).~While
91 II, 5. 5. 3 | based on the 1st quarter of 2004, second generation antipsychotics
92 II, 5. 5. 3 | Poland (Fricke and Pirck, 2004). Differences in usage of
93 II, 5. 5. 3 | Mental Health Surveys (WHO, 2004), which were linked to the
94 II, 5. 5. 3 | ESEMeD) (Demyttenaere et al, 2004). The authors concluded
95 II, 5. 5. 3 | Spain and Ukraine (WHO, 2004). While the need for treatment
96 II, 5. 5. 3 | Andlin-Sobocki & Rössler, 2005).~In 2004, the costs for hospital
97 II, 5. 5. 3 | service for year 2002 and 2004 with respect to F20-F29~
98 II, 5. 5. 3 | telephone surveys from 2001 to 2004. Nervenarzt Apr 4; Epub
99 II, 5. 5. 3 | Health Survey Consortium (2004): Prevalence, severity,
100 II, 5. 5. 3 | 252-259.~Fricke and Pirk (2004): Defizite in der Arzneimittelversorgung
101 II, 5. 5. 3 | HJ, Gaebel W, Wölwer W (2004): Early detection and secondary
102 II, 5. 5. 3 | S, Levav I, Saraceno B (2004): The treatment gap in mental
103 II, 5. 5. 3 | Health Survey Consortium (2004): Prevalence, severity,
104 II, 5. 5. 3 | comparisons. A study published in 2004 (Blaxill, 2004) looks at
105 II, 5. 5. 3 | published in 2004 (Blaxill, 2004) looks at the different
106 II, 5. 5. 3 | References~ ~Blaxill MF (2004): What’s Going On? The Question
107 II, 5. 5. 3 | treatment initiation (Forsgren, 2004). Active epilepsy is defined
108 II, 5. 5. 3 | vary from 25 to 51% (Beghi, 2004). The main etiological factors
109 II, 5. 5. 3 | Modified from Forsgren, 2004 and Forsgren et al., 2005~ ~
110 II, 5. 5. 3 | adults. As shown by Forsgren (2004) in prevalence studies made
111 II, 5. 5. 3 | children and adults (Jallon, 2004) (Table 5.5.3.4.4). These
112 II, 5. 5. 3 | incidence cohorts (Jallon, 2004).~These rates were not significantly
113 II, 5. 5. 3 | between 7 and 50 (Forsgren, 2004). Remote symptomatic seizures
114 II, 5. 5. 3 | 6 (Gaitatzis and Sander, 2004). Patients with epilepsy
115 II, 5. 5. 3 | seizure-related (Tomson et al, 2004). In these populations,
116 II, 5. 5. 3 | unstable treatment (Jallon, 2004). SUDEP is rare in community-based
117 II, 5. 5. 3 | from 4.5 to 32 (Jallon, 2004). In a population-based
118 II, 5. 5. 3 | epilepsy (Gaitatzis et al, 2004). Records were taken of
119 II, 5. 5. 3 | Database (Gaitatzis et al, 2004). The ICD-9 coding system
120 II, 5. 5. 3 | children was 74-78% (Forsgren, 2004). In the Finnish cohort
121 II, 5. 5. 3 | epilepsy (Jacoby et al, 2004). In addition, unemployment
122 II, 5. 5. 3 | Van den Broek and Beghi, 2004). Intervention studies on
123 II, 5. 5. 3 | Lay, 1997; Sheth et al, 2004). In addition, mandatory
124 II, 5. 5. 3 | License Committee of the EU in 2004. This group, which was represented
125 II, 5. 5. 3 | Epilepsia 43:1076-1083.~Beghi E (2004): Aetiology of epilepsy.
126 II, 5. 5. 3 | 37:224-229.~Forsgren L (2004): Epidemiology and prognosis
127 II, 5. 5. 3 | Gaitatzis A, Sander JW (2004): The mortality of epilepsy
128 II, 5. 5. 3 | K, Majeed A, Sander JW (2004): The epidemiology of the
129 II, 5. 5. 3 | Gorry J, Gamble C, Baker GA (2004): Public knowledge, private
130 II, 5. 5. 3 | 45:1405-1415.~Jallon P (2004): Mortality in patients
131 II, 5. 5. 3 | Krauss G, Krumholz A. Li G (2004): Mortality in epilepsy:
132 II, 5. 5. 3 | Sundqvist A, Johannessen SI (2004): Medical risks in epilepsy:
133 II, 5. 5. 3 | E, for the RESt-1 group (2004): Accidents in patients
134 II, 5. 5. 3 | higher MS incidence (WHO, 2004), thus proportional greater
135 II, 5. 5. 3 | vs 38%) (Fangerau et al, 2004).~Lastly, the lack of “attacks”
136 II, 5. 5. 3 | Sclerosis (Battaglia et al, 2004).~These recommendations
137 II, 5. 5. 3 | References~ ~Bajenaru O, Pascu I (2004): Report of multiple sclerosis
138 II, 5. 5. 3 | Ketelaer P, Thompson A et al; (2004): Recommendations on Rehabilitation
139 II, 5. 5. 3 | 98:238-242.~Berkowicz T (2004): Report of multiple sclerosis
140 II, 5. 5. 3 | Koch-Henriksen N, Stenager E (2004): Trends in survival and
141 II, 5. 5. 3 | KM, Nyland H, Midgard R (2004): Multiple sclerosis in
142 II, 5. 5. 3 | Ekestern E, Lebhart G (2004). Mortality from multiple
143 II, 5. 5. 3 | European Governments on-line (2004): Available at: www tm Accessed
144 II, 5. 5. 3 | Accessed Sept 6 2004.~Fangerau T, Schimrigk S,
145 II, 5. 5. 3 | Schimrigk S, Haupts M, et al (2004): Diagnosis of multiple
146 II, 5. 5. 3 | 56(2):78-105~Horakova D (2004): Report of multiple sclerosis
147 II, 5. 5. 3 | McCarthy A, Quigley C, et al (2004): Latitudinal variation
148 II, 5. 5. 3 | C, Baldwin D, Mayers A (2004). Changing patterns of adult (
149 II, 5. 5. 3 | Wikström J, Paltamaa J, et al (2004): Occurrence of multiple
150 II, 5. 5. 3 | Svenningsson A, Nyström L, et al (2004): Clinical characteristics
151 II, 5. 5. 3 | Estimates. In: WHO Health Report 2004.~World Health Organization (
152 II, 5. 5. 3 | The world health report 2004 - changing history. WHO,
153 II, 5. 5. 3 | 2003; Bergareche et al, 2004; Chio et al, 1998; D’Alessandro
154 II, 5. 5. 3 | EUGLOREH countries (€PPP, 2004)~ ~The total cost of PD
155 II, 5. 5. 3 | estimated at €10.7 billion in 2004 in EU25 and EFTA countries.
156 II, 5. 5. 3 | and Tranchant, 2007; Quik, 2004; Chade et al 2006). However,
157 II, 5. 5. 3 | al, 1999; Gorell et al, 2004).~ ~
158 II, 5. 5. 3 | European Commission, 2001-2004 (htt . EuroPa aimed at establishing
159 II, 5. 5. 3 | disease. (EuroPa Consortium, 2004)~The European Brain Council (
160 II, 5. 5. 3 | Poza JJ, Marti-Masso JF (2004): Prevalence of Parkinson’
161 II, 5. 5. 3 | 604.~EuroPa Consortium (2004): A European Network for
162 II, 5. 5. 3 | Rybicki BA, Johnson CC (2004): Multiple risk factors
163 II, 5. 5. 3 | Available at: htt f.~Quik M (2004): Smoking, nicotine and
164 II, 5. 6. 2 | 2005 (European Commission (2004): European Action Towards
165 II, 5. 6. 3 | participation (European Commission (2004): European Action Towards
166 II, 5. 6. 3 | et al, 1999; Woolf et al, 2004). Musculoskeletal conditions
167 II, 5. 6. 3 | disability (European Commission (2004): European Action Towards
168 II, 5. 6. 3 | disability (European Commission (2004): European Action Towards
169 II, 5. 6. 3 | al, 1993; Johnell et al, 2004).~ ~Future trends~ ~The
170 II, 5. 6. 5 | Health (European Commission (2004): European Action Towards
171 II, 5. 6. 6 | European Commission (2004): European Action Towards
172 II, 5. 6. 6 | C, De Laet C, Jonsson B (2004): Mortality after osteoporotic
173 II, 5. 6. 6 | Veale DJ, Martin-Mola E (2004): Musculoskeletal pain in
174 II, 5. 7. 1 | Organization, 2005; Yach et al, 2004). However, it is exceedingly
175 II, 5. 7. 1 | obesity (Rodgers et al, 2004) and consume a large fraction
176 II, 5. 7. 1 | in the USA (Smith et al, 2004). A considerable amount
177 II, 5. 7. 3 | pmarp) (Ardissino et al., 2004). In the Swedish study (
178 II, 5. 7. 3 | observed for CKD (Hsu et al, 2004). Indeed, 9 new cases of
179 II, 5. 7. 3 | fruit (Gansevoort et al, 2004; Stewart et al, 2006). The
180 II, 5. 7. 3 | Van der Heijden et al, 2004). In 2005 the prevalence
181 II, 5. 7. 3 | evolution to ESRD (Go et al, 2004) - in population-based studies
182 II, 5. 7. 3 | 1988-1994 and between 1999-2004 respectively). In those
183 II, 5. 7. 3 | fruit (Gansevoort et al, 2004; Stewart et al, 2006). The
184 II, 5. 7. 5 | assessed at regional level. In 2004 the French Ministry of Health
185 II, 5. 7. 7 | Nieuwenhuizen MG, de ZD, et al (2004): Trends in the incidence
186 II, 5. 7. 7 | future? Kidney Int Suppl 2004 Nov;(92):S7-10.~Gansevoort
187 II, 5. 7. 7 | D, McCulloch CE, Hsu CY (2004): Chronic kidney disease
188 II, 5. 7. 7 | hospitalization. N Engl J Med 2004 Sep 23;351(13):1296-305.~
189 II, 5. 7. 7 | Vittinghoff E, Lin F, Shlipak MG (2004): The incidence of end-stage
190 II, 5. 7. 7 | insufficiency. Ann Intern Med 2004 Jul 20;141(2):95-101.~Jager
191 II, 5. 7. 7 | disease. Am J Kidney Dis 2004;43(Suppl 1):S1-S290.~Obrador
192 II, 5. 7. 7 | Lopez AD, Lin RB, Murray CJ (2004): Distribution of major
193 II, 5. 7. 7 | Nichols G, Keith DS, Brown JB (2004): Cost of medical care for
194 II, 5. 7. 7 | population. J Am Soc Nephrol 2004 May;15(5):1300-6.~Stengel
195 II, 5. 8. 2 | reported asthma (Viegi et al 2004).~ ~Table 5.8.2.1. ICD10
196 II, 5. 8. 3 | guidelines (De Marco et al, 2004). These results are reported
197 II, 5. 8. 3 | patients with COPD (Rea et al 2004; GOLD 2006)~ ~A relevant
198 II, 5. 8. 3 | Amsterdam by Kriegsman et al (2004), apart from observing that
199 II, 5. 8. 3 | study by Mikkelsen et al (2004) found that clinical significant
200 II, 5. 8. 3 | a study by Wagena et al (2004) smoker patients with asthma
201 II, 5. 8. 3 | study by Sprenkle et al (2004), SF-36V was used in a large
202 II, 5. 8. 3 | consumption (Detournay et al, 2004). Moreover, the costs increased
203 II, 5. 8. 3 | 909€ in Spain (Masa et al, 2004) and 1 261€ in Italy.~ ~
204 II, 5. 8. 4 | respectively (De Marco et al, 2004).~ ~In a review of community
205 II, 5. 8. 4 | workers (Bergahl et al, 2004). In the European Community
206 II, 5. 8. 5 | guidelines have been issued: in 2004 by the American Thoracic
207 II, 5. 8. 5 | Society (ERS) (Celli et al, 2004), which is updated every
208 II, 5. 8. 7 | Flodin R, and Järvholm B (2004): Increased mortality in
209 II, 5. 8. 7 | position paper. Eur Respir J 2004; 23: 932-946.~ ~Cerveri
210 II, 5. 8. 7 | Svanes C, Anto JM, Burney P (2004): European Community Respiratory
211 II, 5. 8. 7 | according to GOLD stages. Thorax 2004; 59: 120–125.~ ~Detournay
212 II, 5. 8. 7 | Jourdanne C, Durand-Zaleski I (2004): SCOPE Group. The SCOPE
213 II, 5. 8. 7 | in France. Value Health 2004; 7: 168-174.~ ~European
214 II, 5. 8. 7 | DM, Deeg DJ, Stalman WA (2004): Comorbidity of somatic
215 II, 5. 8. 7 | Amsterdam. J Clin Epidemiol 2004; 57: 55-65.~ ~Lindberg A,
216 II, 5. 8. 7 | Viejo JL, Miravitlles M. (2004):Costs of chronic obstructive
217 II, 5. 8. 7 | T, Pisinger C, Stage KB (2004): Anxiety and depression
218 II, 5. 8. 7 | review. Nord J Psychiatry 2004; 58: 65-70.~ ~Miravitlles
219 II, 5. 8. 7 | Roseman P, Didsbury P (2004): A chronic disease management
220 II, 5. 8. 7 | pulmonary disease. Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer
221 II, 5. 8. 7 | DE, Nelson DB, Nichol KL (2004): The Veterans Short Form
222 II, 5. 8. 7 | of asthma or COPD. Chest 2004; 126: 81-89.~ ~Stratelis
223 II, 5. 8. 7 | Molstad S, Zetterstrom O. (2004): Early detection of COPD
224 II, 5. 8. 7 | 55 years. Br J Gen Pract 2004; 54: 201-206.~ ~Sunyer J,
225 II, 5. 8. 7 | Soriano JB, Carrozzi L (2004): The proportionalVenn diagram
226 II, 5. 8. 7 | general population. Chest 2004; 126; 1093-1101.~ ~V . (
227 II, 5. 8. 7 | cigarettes. Eur J Epidemiol 2004; 19: 147-53.~ ~Zielinski
228 II, 5. 9. 2 | ECRHS) (Burney et al, 2004).~ ~ISAAC started in 1991.
229 II, 5. 9. 2 | ECRHS) (Burney et al, 2004) was set up in 1993 and
230 II, 5. 9. 2 | January 2000 and 15 June 2004 (tables 5.9.5 to 5.9.7).
231 II, 5. 9. 3 | ECRHS) (Burney et al, 2004) have shown once again that
232 II, 5. 9. 4 | 047), 1999 (n=3,540) and 2004 (n=1,920) in school-children
233 II, 5. 9. 4 | RR 1.20 (0.99, 1.45). By 2004 this sex bias in diagnosis
234 II, 5. 9. 4 | hay fever. From 1989 to 2004 no significant difference
235 II, 5. 9. 4 | person-yrs(-1)). (Torén et al, 2004).~ ~ ~Some environmental
236 II, 5. 9. 4 | hay-fever) (Ventura et al, 2004). A large cross-sectional
237 II, 5. 9. 7 | Austin JB, Burr M, Jeffs D (2004): Trends in prevalence of
238 II, 5. 9. 7 | Questionnaire survey. BMJ 2004; 328:1052-1053.~ ~Baiardini
239 II, 5. 9. 7 | 60:165-170~ ~Burney PGJ (2004): The European Community
240 II, 5. 9. 7 | Initiative for Asthma (GINA) (2004): The global burden of asthma:
241 II, 5. 9. 7 | Suppl):S2-8.~ ~Torén K (2004): A prospective study of
242 II, 5. 9. 7 | RHINE study. Eur Respir J 2004; 24: 942-946~ ~To E, Tosca-Segura
243 II, 5. 9. 7 | Europe, 1997~ ~Ventura MT (2004): Allergy, asthma and markers
244 II, 5. 9. 7 | Southern Italy. Allergy 2004; 59:632-636~ ~Verlato G,
245 II, 5. 10. 1 | food.~(Adapted from EFSA, 2004 and INFOSAN, 2006)~ ~ ~ ~
246 II, 5. 10. 1 | 4-6% in children (EFSA, 2004).~ ~Health consequences
247 II, 5. 10. 1 | central nervous system (EFSA, 2004). As for allergies in general,
248 II, 5. 10. 1 | group considered (EFSA, 2004). A partial explanation
249 II, 5. 10. 1 | in children (Mills et al, 2004).~ ~
250 II, 5. 10. 2 | Woods et al, 2002; EFSA, 2004). Finally, allergic reactions
251 II, 5. 10. 2 | labelling purposes (EFSA, 2004), which is the most updated
252 II, 5. 10. 3 | latter (Løvik and Narmok, 2004). In adults, main foods
253 II, 5. 10. 3 | background factors (EFSA, 2004).~Although very few longitudinal
254 II, 5. 10. 7 | Safety Authority (EFSA) (2004): Opinion of the Scientific
255 II, 5. 10. 7 | 378.~Løvik M and Namork N (2004): The Norwegian reporting
256 II, 5. 10. 7 | P, Crevel RW, Frewer L (2004): Information provision
257 II, 5. 11. 3 | prevention,. In the year 2004, altogether 11,643 patients
258 II, 5. 11. 3 | testing the standard series, 2004. Journal of the European
259 II, 5. 11. 3 | populations (van Coevorden et al, 2004).~ ~Psoriasis~Psoriasis
260 II, 5. 11. 3 | Mahler, 2002; Boyle et al, 2004).~ ~Non-Melanoma skin cancer~
261 II, 5. 11. 5 | Conference, held in Budapest in 2004, the WHO Regional Office
262 II, 5. 11. 7 | JF, Autier P, Ringborg U (2004): Cancer of the skin: a
263 II, 5. 11. 7 | problem in Europe. Ann Oncol 2004;15(1):5-6.~ ~Boyle P, Smans
264 II, 5. 11. 7 | AM, Coenraads PJ, et al (2004) ; Overview of studies of
265 II, 5. 11. 7 | hand-eczema survey. Br J Dermatol 2004;151(2):446-51.~ ~Verboom
266 II, 5. 12. 5 | et al, 2000; Negri et al, 2004; Shepard et al, 2005).~ ~ ~ ~
267 II, 5. 12. 7 | Vecchia C, Franceschi S (2004): B-cell non-Hodgkin's lymphoma
268 II, 5. 13 | inactivity (James et al, 2004; WHO, 2002; WHO Regional
269 II, 5. 13 | EU15 (EU members before 2004) were estimated to be €32.
270 II, 5. 14. 2 | adolescents and adults (Bourgeois, 2004). In Scandinavia, oral health
271 II, 5. 14. 3 | country (Wid m and Eaton, 2004).~In 2000, expenditures
272 II, 5. 14. 8 | Bourgeois DM, Llodra JC (2004): eds. Health Surveillance
273 II, 5. 14. 8 | Quintessence Publishing Co. 2004:81–92.~Bourgeois DM (2004):
274 II, 5. 14. 8 | 2004:81–92.~Bourgeois DM (2004): European Global Oral Health
275 II, 5. 14. 8 | 2007; 369: 51–59.~Wid A (2004): Oral healthcare systems
276 II, 5. 14. 8 | Oral Health Prev Dent. 2004; 2:155-94.~World Health
277 II, 5. 15. 1 | van Weely and Leufkens, 2004; Wastfelt et al, 2004).
278 II, 5. 15. 1 | Leufkens, 2004; Wastfelt et al, 2004). Among the most common
279 II, 5. 15. 3 | prices were set (ALCIMED, 2004). Several articles have
280 II, 5. 15. 4 | EC and Regulation No 726/2004, adopted (in first reading)
281 II, 5. 15. 4 | Public Health established in 2004 a Rare Diseases Task Force
282 II, 5. 15. 6 | 6. References~ ~ALCIMED (2004): Study on Orphan Drugs.
283 II, 5. 15. 6 | and Regulation (EC) No 726/2004. Available at: htt L (accessed
284 II, 5. 15. 6 | Van Weely S, Leufkens HGM (2004): Orphan Diseases in “Priority
285 II, 6. 2 | trends for the years 1995–20041. This information is complemented
286 II, 6. 3. 1 | population of 16 million) in 2004 the cost attributable to
287 II, 6. 3. 3 | cases in 1996 to 6 386 in 2004. This increase is largely
288 II, 6. 3. 3 | cases in 2001 to 4 151 in 2004. The number of newly diagnosed
289 II, 6. 3. 3 | from 1 491 to 860 cases in 2004), although data are unavailable
290 II, 6. 3. 3 | trends over the period 1995–2004 were observed in the Nordic
291 II, 6. 3. 3 | Europe has again, since 2004, been noted in several large
292 II, 6. 3. 3 | per 100 000 per year in 2004. In the low-incidence countries
293 II, 6. 3. 3 | Gonorrhoea within the EU, 1995 - 2004~ ~Syphilis~ ~Syphilis significantly
294 II, 6. 3. 3 | per 100 000 per year in 2004, mainly due to outbreaks
295 II, 6. 3. 3 | was observed from 1996 to 2004. In some central European
296 II, 6. 3. 3 | per 100 000 per year in 2004, but this increase may possibly
297 II, 6. 3. 4 | public health threat.~ ~The 2004–05 influenza season in Europe
298 II, 6. 3. 4 | started in late December 2004 with the first influenza
299 II, 6. 3. 4 | influenza strain of the 2004–05 and 2005–06 winter seasons
300 II, 6. 3. 4 | Cases of TB between 1995 and 2004~ ~ ~ ~Table 6.A1.3 Cases
301 II, 6. 3. 4 | Europe which joined the EU in 2004, where TB rates are moderate,
302 II, 6. 3. 4 | of legionellosis 1995 - 2004.~ ~The incidence of legionellosis
303 II, 6. 3. 5 | in Europe between 1995 - 2004.~ ~This drop is mainly due
304 II, 6. 3. 5 | notably Poland in 1998 and 2004, Estonia in 1998, France
305 II, 6. 3. 6 | Campylobacteriosis trends between 1995 - 2004~ ~In 2005, more than 200
306 II, 6. 3. 6 | increase in incidence since 2004 . This could be due to improved
307 II, 6. 3. 6 | by Italy between 1995 and 2004 (6 440 cases). In 2005,
308 II, 6. 3. 6 | trend. The incidence in 2004 (0.28 per 100 000 per year)
309 II, 6. 3. 6 | cases (0.87 per 100 000)) to 2004 (1 743 cases (0.38 per 100
310 II, 6. 3. 6 | Europe between 1995 and 2004, and during this period
311 II, 6. 3. 6 | declined steadily until 2004~In 2005, a total of 21 cases
312 II, 6. 3. 7 | EU during the period 1995–2004, ranging from 0.1 to 0.22
313 II, 6. 3. 7 | years (687) was reported in 2004. France continues to report
314 II, 6. 4. 4 | founding Regulation EC N° 851/2004, the ECDC plays a key role
315 II, 7. 2. 4 | being the reference year 2004.~htt ~ ~
316 II, 7. 2. 7 | was developed in 2004 by an EU-funded project
317 II, 7. 3. 2 | Standardised Death Rates (1995-2004, Index = 1995), EU27~ ~
318 II, 7. 3. 4 | definition according to WHO, 2004) and 1.7 million injured
319 II, 7. 3. 5 | suicide (Guo and Harstall, 2004).~ ~Globally seen, in modern
320 II, 7. 4. 2 | report by Todd & Skelton 2004, the policy guideline “Priorities
321 II, 7. 4. 3 | cyclists) were killed in 2004 (Working Group of Governmental
322 II, 7. 4. 6 | strategies (Guo and Harstall, 2004).~ ~
323 II, 7. 5 | WHO, 2007; Racioppi et al, 2004). The areas of action are
324 II, 7. 5 | collection (Holder et al, 2004). Through a series of projects,
325 II, 7. 7 | HU, LV, NL, PT, SI, SE (2004) EE, IT (2003) [https://
326 II, 7. 7 | 2008].~ ~Guo B, Harstall C (2004). For which strategies of
327 II, 7. 7 | Tingvall C, Villaveces A (2004): Preventing Road Traffic
328 II, 7. 7 | Europe.~ ~Todd C, Skelton D. (2004): What are the main risk
329 II, 7. 7 | Health Organization (WHO) (2004): World Report on Road Traffic
330 II, 8. 1. 2 | first data collection in 2004. This survey covers only
331 II, 8. 1. 5 | phase of the Action Plan (2004-2005) addressed the establishment
332 II, 8. 1. 5 | priorities for action during 2004-2005. The second phase of
333 II, 8. 2. 1 | funded by DG-SANCO 2002-2004, concluded (Linehan et al
334 II, 8. 2. 1 | concluded (Linehan et al 2004). However, some countries –
335 II, 8. 2. 1 | Rowe1998; Mason & Scior 2004). Visual and dental care
336 II, 8. 2. 1 | behavioural issues (Fisher 2004).~Arguably, stigmatisation
337 II, 8. 2. 1 | 51, 866-874.~Fisher, K., (2004). Health Disparities and
338 II, 8. 2. 1 | Scholarship, First Quarter 2004, 48-53~Fujiura, G.T., Park,
339 II, 8. 2. 1 | Mason, J., & Scior, K., (2004). Diagnostic overshadowing
340 II, 8. 2. 2 | impairment (Pascolini et al, 2004) is an important source
341 II, 8. 2. 2 | the EU SILC carried out in 2004. The results obstained with
342 II, 8. 2. 2 | out by Resnikoff et al (2004). Prevalence of blindness
343 II, 8. 2. 2 | Iceland) (Resnikoff et al, 2004). Estimates for Bulgaria
344 II, 8. 2. 2 | out by Resnikoff et al (2004). Prevalence of blindness
345 II, 8. 2. 2 | Iceland) (Resnikoff et al, 2004). Estimates for Bulgaria
346 II, 8. 2. 2 | new Member States (Kocur, 2004)~ ~
347 II, 8. 2. 2 | Epidemiology 6:73-82.~Kocur I (2004): Fifteen years of eye health
348 II, 8. 2. 2 | ale D, Négrel A-D, et al. (2004): 2002 Global update of
349 II, 8. 2. 2 | Pokharel GP and Mariotti SP (2004): Global data on visual
350 II, 8. 2. 2 | uncorrected refractive errors in 2004 Bulletin of the World Health
351 II, 8. 2. 3 | the EU SILC carried out in 2004. The results obtained with
352 II, 8. 2. 3 | Living Conditions (EU-SILC) (2004): Database available at: htt ~ ~
353 II, 9 | morbidity (Maher and Macfarlane, 2004). Older mothers and nulliparas
354 II, 9 | stillbirth (Canterino et al, 2004; Raymond et al, 1994; Reddy
355 II, 9 | and Brown, 2007b; Magee 2004). This increased risk is
356 II, 9 | al, 2005; Garite et al, 2004). Figures 9.T1.1 and 9.T1.
357 II, 9 | et al, 1999; Cnattingius, 2004). These effects concern
358 II, 9 | congenital anomaly risk (EUROCAT, 2004; Macintosh et al, 2006),
359 II, 9 | Waller, 2007; EUROCAT, 2004). In the case of epilepsy
360 II, 9 | Vrijheid, 2003; EUROCAT, 2004). To protect the fetus,
361 II, 9 | 1996; Matharu and Ozanne, 2004; Ozanne et al, 2004).~ ~
362 II, 9 | Ozanne, 2004; Ozanne et al, 2004).~ ~Smoking. Smoking is
363 II, 9 | society's terms (Jarvis, 2004). Data from ESPAD from 16
364 II, 9 | peaks in Denmark (WHO/HSBC, 2004; www rg interactive data) (
365 II, 9 | and Switzerland (WHO/HSBC, 2004), though in ESPAD data the
366 II, 9 | sexual health (WHO/HSBC, 2004).~ ~Inadequate physical activity.
367 II, 9 | media pressure (WHO/HSBC 2004). Although varying widely
368 II, 9 | during the day (WHO/HSBC 2004).~ ~Disability. Regrettably,
369 II, 9 | behaviors (De Groot et al, 2004). Member States should consider
370 II, 9 | important risk factor (WHO/HEN, 2004).~ ~References cited in
371 II, 9. 1. 1 | current EU Member States. By 2004, they ranged from 1.6 to
372 II, 9. 1. 1 | of neonatal mortality in 2004 was 2.7 per 1 000 births.
373 II, 9. 1. 1 | countries that joined the EU in 2004 (Czech Republic, Cyprus,
374 II, 9. 1. 1 | greater downward trend. Using 2004 data, there was no difference
375 II, 9. 1. 1 | and those who joined in 2004. The median rate of foetal
376 II, 9. 1. 1 | Harrigan JT, Vintzileos AM (2004): Maternal age and risk
377 II, 9. 1. 1 | Matern Fetal Neonatal Med 2004;15(3):193-7.~Castles A,
378 II, 9. 1. 1 | 983-90.~Cnattingius S (2004): The epidemiology of smoking
379 II, 9. 1. 1 | outcomes. Nicotine Tob Res 2004;6 Suppl 2:S125-40.~Cnattingius
380 II, 9. 1. 1 | RH, Elliott JP, Thorp JA (2004): Twins and triplets: the
381 II, 9. 1. 1 | infants. Am J Obstet Gynecol 2004;191(3):700-7.~Garne E (2001):
382 II, 9. 1. 1 | KA, Wu YW, Croughan MS (2004): Perinatal outcomes in
383 II, 9. 1. 1 | meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kramer
384 II, 9. 1. 1 | Lin HC, Xirasagar S (2004): Institutional factors
385 II, 9. 1. 1 | implications. Obstet Gynecol 2004;103(1):128-36.~Luke B, Brown
386 II, 9. 1. 1 | 88(2):283-93.~Magee BD (2004): Role of multiple births
387 II, 9. 1. 1 | mortality. J Reprod Med 2004;49(10):812-6.~Maher J, Macfarlane
388 II, 9. 1. 1 | Maher J, Macfarlane A (2004): Inequalities in infant
389 II, 9. 1. 1 | 1976-2000. Health Stat Q 2004(24):14-22.~Olausson PM,
390 II, 9. 1. 2 | per 1 000 births for 2000-2004 (Table 9.1.2.1). Total prevalence
391 II, 9. 1. 2 | congenital anomaly subgroups 2000-2004~ ~The average prevalence
392 II, 9. 1. 2 | Cardiac Anomalies, 1992-2004.~ ~Perinatal mortality and
393 II, 9. 1. 2 | congenital anomalies, 2000-2004.~ ~Perinatal mortality due
394 II, 9. 1. 2 | births, by country, 2000-2004~ ~The ratio of TOPFA to
395 II, 9. 1. 2 | births of Down Syndrome, 1992-2004~ ~Prenatal screening for
396 II, 9. 1. 2 | in maternal age. In 2000-2004, differences in policy and
397 II, 9. 1. 2 | syndrome per country, 2000-2004~ ~Neural Tube Defects~ ~
398 II, 9. 1. 2 | Neural Tube Defects, 1992-2004~ ~During the 1980s and previously,
399 II, 9. 1. 2 | al, 2005b). In the 2000-2004 period, the total prevalence
400 II, 9. 1. 2 | and 1.6 per 1 000 for 2000-2004 (EUROCAT, 2007), while rates
401 II, 9. 1. 2 | per 1 000 births in 2000-2004 (Table 9.1.2.1). It is associated
402 II, 9. 1. 2 | 1 000 in the period 2000-2004, and two areas report a
403 II, 9. 1. 2 | are accessed (Dolk et al, 2004). Criteria may vary over
404 II, 9. 1. 2 | morbidity (Maher and Macfarlane, 2004). Older mothers and nulliparas
405 II, 9. 1. 2 | stillbirth (Canterino et al, 2004; Raymond et al, 1994; Reddy
406 II, 9. 1. 2 | and Brown, 2007b; Magee 2004). This increased risk is
407 II, 9. 1. 2 | al, 2005; Garite et al, 2004). Figures 9.T1.1 and 9.T1.
408 II, 9. 1. 2 | et al, 1999; Cnattingius, 2004). These effects concern
409 II, 9. 1. 2 | congenital anomaly risk (EUROCAT, 2004; Macintosh et al, 2006),
410 II, 9. 1. 2 | Waller, 2007; EUROCAT, 2004). In the case of epilepsy
411 II, 9. 1. 2 | Vrijheid, 2003; EUROCAT, 2004). To protect the fetus,
412 II, 9. 1. 2 | countries (Garne et al, 2004; Garne et al, 2005). Such
413 II, 9. 1. 2 | pregnancy (Green et al, 2004). The option of pregnancy
414 II, 9. 1. 2 | cause distress (Green et al, 2004).~ ~Public health initiatives
415 II, 9. 1. 2 | Linzalone N, Madeddu A (2004): Surveillance of congenital
416 II, 9. 1. 2 | Siracusa. Epidemiol Prev. 2004 Mar-Apr;28(2):87-93.~Botto
417 II, 9. 1. 2 | A, Calzolari E, Stone D (2004): "Towards the Effective
418 II, 9. 1. 2 | Ulster.[www l]~EUROCAT (2004): "EUROCAT Special Report:
419 II, 9. 1. 2 | Loane M, de Vigan C et al (2004): “Prenatal Diagnostic Procedures
420 II, 9. 1. 2 | HL, Bryant LD, Cuckle HS (2004): Psychosocial aspects of
421 II, 9. 1. 2 | systematic review. HTA Assessment 2004; Vol 8, no. 33.~Hansen M,
422 II, 9. 2. 1 | and Lithuania (WHO/HSBC, 2004).~ ~The World Health Organization (
423 II, 9. 2. 2 | the standard (Robine et al 2004). Organisations such as
424 II, 9. 2. 2 | countries of the EU (De Smedt, 2004). Moreover, the focus is
425 II, 9. 2. 2 | underage employment (WHO/HSBC 2004). These groups may be living
426 II, 9. 2. 3 | of asthma” (Masoli et al, 2004?), a report developed for
427 II, 9. 2. 3 | previous 12 months (HBSC, 2004). Unintentional injuries
428 II, 9. 2. 3 | in Context study (HBSC, 2004) bullying occurring on average
429 II, 9. 2. 3 | reported among girls (WHO/HSBC, 2004). Bullying is one specific
430 II, 9. 2. 3 | years of age (WHO/HSBC, 2004). For both biological and
431 II, 9. 2. 3 | report dieting (WHO/HSBC, 2004). In several countries of
432 II, 9. 2. 3 | endocrine disorders (WHO/HSBC 2004). Malta and Wales have among
433 II, 9. 2. 3 | muscle-enhancing activities (WHO/HSBC 2004). Self-assessment of BMI
434 II, 9. 2. 3 | Neumark-Sztainer et al 2004).~ ~Mental Health: Mental
435 II, 9. 2. 4 | 1996; Matharu and Ozanne, 2004; Ozanne et al, 2004).~ ~
436 II, 9. 2. 4 | Ozanne, 2004; Ozanne et al, 2004).~ ~Smoking. Smoking is
437 II, 9. 2. 4 | society's terms (Jarvis, 2004). Data from ESPAD from 16
438 II, 9. 2. 4 | peaks in Denmark (WHO/HSBC, 2004; www rg interactive data) (
439 II, 9. 2. 4 | and Switzerland (WHO/HSBC, 2004), though in ESPAD data the
440 II, 9. 2. 4 | sexual health (WHO/HSBC, 2004).~ ~Inadequate physical activity.
441 II, 9. 2. 4 | media pressure (WHO/HSBC 2004). Although varying widely
442 II, 9. 2. 4 | during the day (WHO/HSBC 2004).~ ~Disability. Regrettably,
443 II, 9. 2. 5 | European children (WHO, 2004). It was developed at the
444 II, 9. 2. 5 | Environment and Health (2004) on "The future for our
445 II, 9. 2. 5 | 2010” (European Commission, 2004)~ ~
446 II, 9. 2. 7 | accessed 28 January 2004):~ ~Council of the European
447 II, 9. 2. 7 | Brussels.~ ~De Smedt, M. (2004): Towards A Common Framework
448 II, 9. 2. 7 | Luxembourg~ ~European Commission (2004): Communication from the
449 II, 9. 2. 7 | Environment & Health Action Plan 2004-2010” COM(2004) 416 final.
450 II, 9. 2. 7 | Action Plan 2004-2010” COM(2004) 416 final. Available at:~htt ~ ~
451 II, 9. 2. 7 | Commission, Luxembourg~ ~HBSC (2004): Young people’s health
452 II, 9. 2. 7 | Belgium)~ ~Jarvis, MJ (2004): Why People Smoke. British
453 II, 9. 2. 7 | Fabian D, Holt S, Beasley R (2004?): Global Burden of Asthma [
454 II, 9. 2. 7 | Matharu, K., Ozanne, S (2004): The Fetal Origins of Disease
455 II, 9. 2. 7 | NeoReviews Vol.5 No.12 2004 e522. American Academy of
456 II, 9. 2. 7 | Story M; Fulkerson JA. (2004): Are family meal patterns
457 II, 9. 2. 7 | Health; 35(5):350-9, November 2004~ ~Ozanne SE, Fernandez-Twinn
458 II, 9. 2. 7 | Available at:~htt ~ ~WHO/HBSC (2004); Young people’s health
459 II, 9. 2. 7 | Health; WHO, Geneva.~ ~WHO (2004): Children's Environment
460 II, 9. 3. 1 | countries of the EU (De Smedt, 2004).~ ~This section is also
461 II, 9. 3. 1 | European Mental Health Report (2004) and helps explain why men
462 II, 9. 3. 1 | which data was reported in 2004 (excluding Italy and Spain).
463 II, 9. 3. 1 | survival rates (UNAIDS et al, 2004).~ ~Sexually Transmitted
464 II, 9. 3. 1 | malignancy (Fenton and Lowndes, 2004). Nevertheless, about 70
465 II, 9. 3. 1 | disease (Lim & Fitzpatrick, 2004); the treatment of prostate
466 II, 9. 3. 1 | population worldwide (Kvien, 2004). As the disease increases
467 II, 9. 3. 1 | 921 - 931.~ ~De Smedt M (2004): Towards A Common Framework
468 II, 9. 3. 1 | Fenton K A and Lowndes C M (2004): Recent trends in the epidemiology
469 II, 9. 3. 1 | 255-263; doi:10.1136/sti.2004.009415~ ~Forsgren L, Beghi
470 II, 9. 3. 1 | Lim LS, Fitzpatrick RD (2004): Osteoporosis in Men. In
471 II, 9. 3. 1 | Tsuboi K, Dennerstein L (2004); Prevalence of eating disorders:
472 II, 9. 3. 1 | UNAIDS, UNFPA, and UNIFEM (2004): Women and HIV/AIDS Confronting
473 II, 9. 3. 2 | to 26 per 100 000 in 2002-2004, still the highest among
474 II, 9. 3. 2 | two-year period 2003 and 2004, there is a substantial
475 II, 9. 3. 2 | selected EUGLOREH countries in 2004-2006~ ~For a few countries -
476 II, 9. 3. 2 | 1989; Lin and Xirasagar, 2004). Caesarean delivery is
477 II, 9. 3. 2 | infertility problems. In 2004, up to 3-4% of newborns
478 II, 9. 3. 2 | Member States entering EU in 2004, the percentage is even
479 II, 9. 3. 2 | al, 2002; Jackson et al, 2004). Improved antenatal screening
480 II, 9. 3. 2 | Harrigan JT, Vintzileos AM (2004): Maternal age and risk
481 II, 9. 3. 2 | Matern Fetal Neonatal Med 2004;15(3):193-7.~ ~Castles A,
482 II, 9. 3. 2 | 16-21.~ ~Cnattingius S (2004): The epidemiology of smoking
483 II, 9. 3. 2 | outcomes. Nicotine Tob Res 2004;6 Suppl 2:S125-40.~ ~De
484 II, 9. 3. 2 | RH, Elliott JP, Thorp JA (2004): Twins and triplets: the
485 II, 9. 3. 2 | infants. Am J Obstet Gynecol 2004;191(3):700-7.~ ~Garne E (
486 II, 9. 3. 2 | KA, Wu YW, Croughan MS (2004): Perinatal outcomes in
487 II, 9. 3. 2 | meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kahn B,
488 II, 9. 3. 2 | Lin HC, Xirasagar S (2004): Institutional factors
489 II, 9. 3. 2 | implications. Obstet Gynecol 2004;103(1):128-36.~ ~London:
490 II, 9. 3. 2 | Livinstone, 1981.~ ~Magee BD (2004): Role of multiple births
491 II, 9. 3. 2 | mortality. J Reprod Med 2004;49(10):812-6.~ ~Maher J,
492 II, 9. 3. 2 | Maher J, Macfarlane A (2004): Inequalities in infant
493 II, 9. 3. 2 | 1976-2000. Health Stat Q 2004(24):14-22.~ ~Marret S, Ancel
494 II, 9. 3. 3 | World Health Assembly (WHO, 2004)~ ~Risky sexual behaviour
495 II, 9. 3. 3 | from Denmark (Kangas et al, 2004), France (Gremy and Beltzer,
496 II, 9. 3. 3 | France (Gremy and Beltzer, 2004), Finland (Haavio-Mannila
497 II, 9. 3. 3 | Portugal (Amaro et al, 2004), Slovenia (Klavs et al,
498 II, 9. 3. 3 | for Europe (Currie et al, 2004). HBSC surveys have started
499 II, 9. 3. 3 | Fig. 1) (Currie et al, 2004). The gender differences
500 II, 9. 3. 3 | age of 15 (Currie at al, 2004). In Romania (Serbanescu
|
|
| |
